FEDERALUnknownLow
Drugs Made In America Acquisition II Corp.
bd_ff45f21f1ce892d0 · schema v1 · pii pii-v1
Full breach record for Drugs Made In America Acquisition II Corp. →Special purpose acquisition company (SPAC) Item 1C disclosure stating it has no business operations beyond identifying acquisition candidates, faces no significant cybersecurity risk, has not adopted a cybersecurity risk management program, and has not encountered any cybersecurity incidents since its IPO. Board of directors generally oversees cybersecurity risk. No breach is disclosed in this filing.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea0285468-10k_drugs2.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Apr 15, 2026
- Raw hash
- 67d7526baccc60a9a485f1839b21efd7bc69d23b07ba21a7826ac0d2b4f50539
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- Drugs Made In America Acquisition II Corp.norm: drugs made in america acquisition ii
- SEC CIK
- 0002040475
Victim entity
- Name
- Drugs Made In America Acquisition II Corp.norm: drugs made in america acquisition ii
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.